Mina Hossein Pour, Vahid Azimirad, Maryam Alimohammadi*, Parviz Shahabi, Mina Sadighi, Ghazaleh Ghamkhari Nejad
|
Yadollah Omidi*
|
Yasamin Baghdadchi, Maryam Khoshkam, Mojtaba Fathi*, Ahmad Jalilvand, Koorosh Fooladzas, Ali Ramazani*
|
Diego Velasquez, Laurent Chaunier, Sofiane Guessasma, Frédéric Faure, Alain Bizeau, Graciela Pavon-Djavid, Anne Meddahi-Pellé, Denis Lourdin*
|
Tatiana Matvienko, Viktoriya Sokolova, Svitlana Prylutska, Yuliia Harahuts, Nataliya Kutsevol, Viktor Kostjukov, Maxim Evstigneev*  , Yuriy Prylutskyy*, Matthias Epple, Uwe Ritter
It was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher toxicity towards HeLa cells, whereas the SWCNT+Dox and GO+Dox nanofluids protected cells from Dox.
|
Siddharth Singh Yadav, Basant Singh Sikarwar*  , Priya Ranjan, Rajiv Janardhanan
We proposed making a case for the validation of a low-cost version of a microfluidic system capable of scanning large populations for a variety of diseases as per the WHO mandate of “One Health”.
|